Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
RecruitingOBSERVATIONAL
Enrollment
50
Participants
Timeline
Start Date
June 24, 2025
Primary Completion Date
April 10, 2030
Study Completion Date
April 10, 2030
Conditions
Sickle Cell Disease
Trial Locations (1)
20892
RECRUITING
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Human Genome Research Institute (NHGRI)
NIH
NCT06944067 - Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease | Biotech Hunter | Biotech Hunter